Considering the absence of symptoms of early carcinomatosis and the current limitations of imaging in detecting early PC, early diagnosis and treatment of PC is very difficult and necessitates development of new therapeutic approaches for patients at high risk of pmCRC. Currently, two therapeutic opportunities, prophylactic or adjuvant HIPEC and second look surgery, both aiming at treating pmCRC in an earlier phase, are under investigation.